Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net income $ 977 $ 283
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 333 252
Share-based compensation expense 89 64
Non-cash interest expense 52 54
Amortization of debt issuance costs, deferred commitment fees, premium and discount 53 53
Loss on modification or extinguishment of debt 27 100
Total losses on derivatives, net 17 108
Net cash used for settlement of derivative instruments (54) (59)
Impairment expense and loss on disposal of assets 8 15
Other (5) (2)
Changes in operating assets and liabilities:    
Accounts and other receivables 115 (33)
Accounts receivable—related party (1) (1)
Inventory (56) 35
Other current assets (35) (45)
Accounts payable and accrued liabilities (23) 20
Deferred revenue 8 58
Other, net (1) (7)
Net cash provided by operating activities 1,504 895
Cash flows from investing activities    
Property, plant and equipment, net (2,712) (2,903)
Investment in equity method investment (25) (41)
Other 15 18
Net cash used in investing activities (2,722) (2,926)
Cash flows from financing activities    
Proceeds from issuances of debt 3,443 6,537
Repayments of debt (1,385) (3,609)
Debt issuance and deferred financing costs (53) (85)
Debt extinguishment costs (16) 0
Distributions and dividends to non-controlling interest (435) (60)
Payments related to tax withholdings for share-based compensation (10) (4)
Other (7) 0
Net cash provided by financing activities 1,537 2,779
Net increase in cash, cash equivalents and restricted cash 319 748
Cash, cash equivalents and restricted cash—beginning of period 2,613 1,827
Cash, cash equivalents and restricted cash—end of period $ 2,932 $ 2,575